Vimarsana
Biggest News Aggregation in the World

Page 11 - Eric Ribner News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eric Ribner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eric Ribner Today - Breaking & Trending Today

Anixa Biosciences to Present at the 2022 H.C. Wainwright Global Investment Conference - Vimarsana News

Anixa Biosciences to Present at the 2022 H.C. Wainwright Global Investment Conference

Published: May 5, 2022

/PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases,...

Source: prnewswire.com
Related Topics:
Eric RibnerMike CatelaniMolgenie GmbLifesci AdvisorsCompany ContactMoffitt Cancer CenterAnixa Biosciences IncAnixa BiosciencesGlobal Investment ConferenceHybrid ConferenceGlobal InvestmentMolgenie GmbhCleveland ClinicLooking StatementsPrivate Securities Litigation Reform ActAnnual ReportQuarterly ReportsCurrent ReportsSci Advisors
Enlivex Announces Issuance of Two U.S. Patents Covering Methods of Treating Sepsis with Allocetra - Vimarsana News

Enlivex Announces Issuance of Two U.S. Patents Covering Methods of Treating Sepsis with Allocetra

Published: May 5, 2022

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
Related Topics:
United StatesEric RibnerOren HershkovitzShachar ShlosbergerExchange CommissionEnlivex Therapeutics LtdHarbor StatementPrivate Securities Litigation Reform ActAnnual ReportGlobe NewswireIntellectual Property
Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting - Vimarsana News

Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting

Published: April 28, 2022

/PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases,...

Source: prnewswire.com
Related Topics:
United StatesEric RibnerGeorge Thomas BuddMike CatelaniMolgenie GmbLifesci AdvisorsAmerican Society Of Clinical OncologyCompany ContactMoffitt Cancer CenterAnixa Biosciences IncLifesci CommunicationsAnixa BiosciencesAmerican SocietyClinical OncologyAnnual MeetingCleveland ClinicMolgenie GmbhPrivate Securities Litigation Reform ActAnnual ReportQuarterly ReportsCurrent ReportsSalve NissanSci Advisors
Todos Medical to Present at the Emerging Growth Conference - Vimarsana News

Todos Medical to Present at the Emerging Growth Conference

Published: April 25, 2022

Press release content from NewMediaWire. The AP news staff was not involved in its creation.

Source: apnews.com
Related Topics:
New YorkUnited StatesTel AvivGerald CommissiongEric RibnerDaniel HirschExchange CommissionCl Pharma LtdTodos Medical LtdProvista Diagnostics IncTodos Medical PresidentEmerging Growth ConferenceEmerging GrowthTodos Medical Emerging GrowthProvista DiagnosticsNew York CityTodos MedicalTodos Biochemical Infrared AnalysesLymphocyte Proliferation TestLympro TestCorporate ContactInvestor Relations ContactCovid 19Middle East
Todos Medical Appoints Philippe Goix as Chief Commercial Officer for Provista Diagnostics - Vimarsana News

Todos Medical Appoints Philippe Goix as Chief Commercial Officer for Provista Diagnostics

Published: April 21, 2022

Press release content from NewMediaWire. The AP news staff was not involved in its creation.

Source: apnews.com
Related Topics:
New YorkUnited StatesTel AvivHaute NormandieGerald CommissiongEric RibnerPhillippe GoixMerck MilliporeDaniel HirschMerck MiliporeSandia Research LaboratoryUniversity Of San FranciscoLawrence Livermore LaboratoryHealth InformationPrism Health Diagnostics IncGuava Technologies IncTodos Medical LtdCompany For GrowthSingulex IncCentre National De Recherche ScientifiqueExchange CommissionLaboratory Information SystemsLife SciencesManagement TeamStanford University